Bronstein, Gewirtz & Grossman LLC Urges Telix Pharmaceuticals Limited Investors to Act: Class Action Filed Alleging Investor Harm
(NASDAQ:TLX), NEW YORK, Jan. 01, 2026 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Telix Pharmaceuticals Limited (NASDAQ: TLX) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities […]